Science News Establishment and validation of a prognostic nomogram for overall survival in type II endometrial carcinoma patients March 6, 2025
Science News Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial March 5, 2025
